|
Antidepressant Induced Sexual Dysfunction in Women
Antidepressants are frequently associated with sexual
dysfunction which may include; desire, arousal and orgasm.
Other drugs are often prescribed along with the
antidepressant in an attempt gain some relief of sexual
dysfunction, but the other medications come with their own
side effect profile resulting in a further diminished
quality of life.
Most women discontinue their antidepressant due to sexual
dysfunction caused by the antidepressant.
Do you need to stop taking the antidepressant to alleviate
sexual dysfunction?
No.
The studies with this Saffron were conducted with women
taking an antidepressant.
With Optimum Solace Also Being Effective For Depression, Was
the Depression Lifted First and Then Sexual Dysfunction
Alleviated?
No.
The women in the study responded favorably to their
antidepressant and they no longer had depression before the
start of this study.
Study Participants:
38 married women aged 18-45 years
Taking antidepressant stably for minimum of 6 weeks
No signs of sexual dysfunction before starting
antidepressant
Responded to antidepressant favorably and depression score
improved significantly
19 women assigned antidepressant and this Saffron
19 women assigned antidepressant and placebo
15mg Saffron given twice daily
Results
Breaking down the final results of the study
The Saffron used was particularly effective in improving the
arousal, lubrication, and pain domains.
This saffron was as safe as the placebo used in the study.
This Saffron significantly improved intercourse-related pain
What you would take:
Optimum Solace
Where Available:
Neuro Genetic Solutions
How Much to Take:
Take 1 veggie capsule twice daily. Each capsule contains
15mg of the Saffron.
When to Take:
Take 1 capsule in the morning and the second capsule 5 to 6
hours later.
Take at least 1 hour apart from medications.
Always check with your prescribing physician before starting
any supplement program.
References
Agha-Hosseini M, Kashani L, Aleyaseen A. 2008. Crocus
sativus L. (saffron) in the treatment of premenstrual
syndrome: a double-blind, randomised and placebo-controlled
trial. BJOG 115(4): 515–519.
Aizenberg D, Zemishlany Z, Weizman A. 1995. Cyproheptadine
treatment of sexual dysfunction induced by serotonin
reuptake inhibitors. Clin Neuropharmacol 18(4): 320–324.
Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH,
Abbasi SH, Akhondzadeh S. 2007. Comparison of petal of
Crocus sativus L. and fluoxetine in the treatment of
depressed outpatients: a pilot double-blind randomized
trial. Prog Neuropsychopharmacol Biol Psychiatry
31(2):439–442.
Akhondzadeh S, Fallah-Pour H, AfkhamK,
JamshidiAH,Khalighi-Cigaroudi F. 2004. Comparison of Crocus
sativus L. and imipramine in the treatment of mild to
moderate depression: a pilot double-blind randomized trial
[ISRCTN45683816]. BMC Complement Altern Med 4: 12.
Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. 2005.
Crocus sativus L. in the treatment of mild to moderate
depression: a doubleblind, randomized and placebo-controlled
trial. Phytother Res 19(2):148–151.
Akhondzadeh S, Sabet MS, Harirchian MH, et al. 2010a.
Saffron in the treatment of patients with mild to moderate
Alzheimer’s disease: a 16-week, randomized and
placebo-controlled trial. J Clin Pharm Ther35(5): 581–588.
Akhondzadeh S, Shafiee SabetM, Harirchian MH, et al. 2010b.
A 22-week, multicenter, randomized, double-blind controlled
trial of Crocus sativus in the treatment of mild-to-moderate
Alzheimer’s disease. Psychopharmacology (Berl) 207(4):
637–643.
Balon R. 1993. Fluoxetine-induced sexual dysfunction and
yohimbine. J Clin Psychiatry 54(4): 161–162.
Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. 2001.
Substitution of an SSRI with bupropion sustained release
following SSRI-induced sexual dysfunction. J Clin Psychiatry
62(3): 185–190.
Feder R. 1991. Reversal of antidepressant activity of
fluoxetine by cyproheptadine in three patients. J Clin
Psychiatry 52(4): 163–164.
Gupta S, Droney T, Masand P, Ashton AK. 1999. SSRI-induced
sexual dysfunction treated with sildenafil. Depress Anxiety
9(4): 180–182.
Hensley PL, Nurnberg HG. 2002. SSRI sexual dysfunction: a
female perspective. J Sex Marital Ther 28Suppl 1: 143–153.
Hosseinzadeh H, Jahanian Z. 2010. Effect of Crocus sativus
L. (saffron) stigma and its constituents, crocin and
safranal, on morphine withdrawal syndrome in mice. Phytother
Res 24(5): 726–730.
Hosseinzadeh H, Sadeghnia HR. 2005. Safranal, a constituent
of Crocus sativus (saffron), attenuated cerebral ischemia
induced oxidative damage in rat hippocampus. J Pharm Pharm
Sci 8(3): 394–399.
Hosseinzadeh H, Sadeghnia HR. 2007. Effect of safranal, a
constituent of Crocus sativus (saffron), on methyl
methanesulfonate (MMS)-induced DNA damage in mouse organs:
an alkaline single-cell gel electrophoresis (comet) assay.
DNA Cell Biol 26(12): 841–846.
Hosseinzadeh H, Younesi HM. 2002. Antinociceptive and
anti-inflammatory effects of Crocus sativus L. stigma and
petal extracts in mice. BMC Pharmacol 2: 7.
Hosseinzadeh H, Ziaee T, Sadeghi A. 2008. The effect of
saffron, Crocus sativus stigma, extract and its
constituents, safranal and crocin on sexual behaviors in
normal male rats. Phytomedicine 15(6–7): 491–495.
Hosseinzadeh H, Modaghegh MH, Saffari Z. 2009. Crocus
sativus L. (Saffron) extract and its active constituents (crocin
and safranal) on ischemia-reperfusion in rat skeletal
muscle. Evid Based Complement Alternat Med 6(3): 343–350.
Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, Motamedshariaty VS,
Mohajeri SA. 2012. Effects of saffron (Crocus sativus L.)
and its active constituent, crocin, on recognition and
spatial memory after chronic cerebral hypoperfusion in rats.
Phytother Res 26(3): 381–386.
Landen M, Eriksson E, Agren H, Fahlen T. 1999. Effect of
buspirone on sexual dysfunction in depressed patients
treated with selective serotonin reuptake inhibitors. J Clin
Psychopharmacol 19(3): 268–271.
Lane RM. 1997. A critical review of selective serotonin
reuptake inhibitorrelated sexual dysfunction; incidence,
possible aetiology and implications for management. J
Psychopharmacol 11(1): 72–82.
Modabbernia A, Sohrabi H, Nasehi AA, et al. 2012. Effect of
saffron on fluoxetine-induced sexual impairment in men:
randomized double-blind placebo-controlled trial.
Psychopharmacology (Berl) 223(4): 381–8.
Montejo A, Majadas S Rizvi SJ, Kennedy SH. 2011. The effects
of agomelatine on sexual function in depressed patients and
healthy volunteers. Hum Psychopharmacol 26(8): 537–42.
Montejo-Gonzalez AL, Llorca G, Izquierdo JA, et al. 1997.
SSRI-induced sexual dysfunction: fluoxetine, paroxetine,
sertraline, and fluvoxamine in a prospective, multicenter,
and descriptive clinical study of 344 patients. J Sex
Marital Ther 23(3): 176–194.
Nahid K, Fariborz M, Ataolah G, Solokian S. 2009. The effect
of an Iranian herbal drug on primary dysmenorrhea: a
clinical controlled trial. J Midwifery Womens Health 54(5):
401–404.
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH.
2005. Hydro-alcoholic extract of Crocus sativus L. versus
fluoxetine in the treatment of mild to moderate depression:
a double-blind, randomized pilot trial. J Ethnopharmacol
97(2): 281–284.
Rosen R, Brown C, Heiman J, et al. 2000. The Female Sexual
Function Index (FSFI): a multidimensional self-report
instrument for the assessment of female sexual function. J
Sex Marital Ther 26(2): 191–208.
Serretti A, Chiesa A. 2009. Treatment-emergent sexual
dysfunction related to antidepressants: a meta-analysis. J
Clin Psychopharmac 29(3): 259–66.
Shamsa A, Hosseinzadeh H, Molaei M, Shakeri MT, Rajabi O.
2009. Evaluation of Crocus sativus L. (saffron) on male
erectile dysfunction: a pilot study. Phytomedicine 16(8):
690–693.
Sidi H, Asmidar D, Hod R, Jaafar NR, Guan NC. 2012.
Hypoactive sexual desire among depressed female patients
treated with selective serotonin reuptake inhibitors: a
comparison between escitalopram and fluoxetine. Int J
Psychiatry Clin Pract 16(1): 41–47.
Wilson LA, Wayman CP, Jackson VM. 2009. Neuropeptide
modulation of a lumbar spinal reflex: potential implications
for female sexual function. J Sex Med 6(4): 947–957.
Woodrum ST, Brown CS. 1998. Management of SSRI-induced
sexual dysfunction. Ann Pharmacother 32(11): 1209–1215.
|